Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of ...

Intuitive Surgical (ISRG) is a Zack Rank #1 (Strong Buy) that develops, manufactures, and markets advanced medical ...

Intuitive Surgical crushes Q3 earnings with $2.51 billion revenue, a 23% jump, fueled by $2.40 EPS and 20% growth in da Vinci ...

Shares of Intuitive Surgical jumped more than 17% in premarket trading on Wednesday after the robotic surgery pioneer ...

A 25% drawdown in this stock is actually fairly common, which suggests right now could be a good time to buy it.

Intuitive Surgical posted higher sales and profit for the third quarter and expects higher growth for its da Vinci surgery system this year. The maker of a robotic surgery systems on Tuesday reported ...

Abner Herrman & Brock sold 9,629 shares of Intuitive Surgical, worth around $4.62 million. As of September 30, 2025, the firm ...

Discover key takeaways from Intuitive Surgical's Q3 2025 earnings: robust da Vinci 5 adoption, global growth, and upgraded financial guidance.

Intuitive Surgical (NASDAQ: ISRG) is a growth stock, hailing from the medical-device segment of the broader healthcare sector ...

Intuitive Surgical reports Q4 2024 revenue of $2.41 billion, up 25%; da Vinci procedures increased by 18%. Intuitive Surgical announced strong financial results for Q4 2024, reporting a 25% increase ...

Intuitive Surgical reports Q1 2025 revenue of $2.25 billion, up 19%, with significant growth in da Vinci procedures and system placements. Intuitive Surgical reported strong financial results for the ...